52.23USD+1.58%Mkt Cap: 1.55B USDP/E: —Last update: 2026-06-01
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and inf…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap1.55B USD
Enterprise Value1.54B USD
Revenue (TTM)442.68M USD
Gross Profit298.17M USD
Net Income (TTM)-21.02M USD
Revenue/Share15.30 USD
Last Price52.23 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)42.23
PEG—
EV/EBITDA-196.30
EV/Revenue3.48
P/S3.49
P/B4.93
EPS (TTM)-2.66
EPS (Forward)1.23
52W Range
32.2114% of range170.87
52W High170.87 USD
52W Low32.21 USD
Profitability
Gross Margin69.74%
Oper. Margin-25.61%
EBITDA Margin-1.77%
Profit Margin-4.92%
ROE-6.82%
ROA-4.01%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF33.28M USD
CapEx (TTM)19.02M USD
FCF Margin0.82%
FCF Yield0.23%
Net Debt-2.49M USD
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity0.37
Current Ratio3.09
Quick Ratio2.83
Book Value/Sh10.54 USD
Cash/Share5.749 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:33
Split DateMay 4, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)77.00 USD
Target Range50.00 USD – 100.00 USD
# Analysts9
Ownership
Shares Out.29.69M
Float18.81M
Insiders12.12%
Institutions112.74%
Short Interest
Short Ratio2.9d
Short % Float31.93%
Short % Out.16.61%
Shares Short4.93M
Short (prev mo.)3.96M
Technical
SMA 5057.52 (-9.2%)
SMA 200104.25 (-49.9%)
Beta2.07
S&P 52W Chg27.70%
Avg Vol (30d)1.64M
Avg Vol (10d)1.38M
Technical Indicators
RSI (14)51.1
MACD-2.7904
MACD Signal-4.7679
MACD Hist.+1.9775
BB Upper62.91 USD
BB Middle45.28 USD
BB Lower27.64 USD
BB Width77.91%
ATR (14)4.472 USD
Vol Ratio (20d)0.32x